Digital Community to Improve Health in Rural Areas

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

459 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-12

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a cluster randomized controlled trial developed in counties located in Appalachia and the Midwest. We will prioritize counties from states with high risk for HIV and HCV infection associated with injection drug use.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Brief Intervention for Rural Women at High Risk for HIV/HCV

NCT01840722

Acquired Immune Deficiency Syndrome Virus Hepatitis C Drug Abuse

COMPLETED NA

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

NCT05669534

Hiv Opioid Use Disorder

RECRUITING PHASE4

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

NCT05547048

HIV Opioid Use Disorder eHealth

RECRUITING PHASE4

Appalachian Partnership to Reduce Disparities (Aim 2)

NCT04378439

HIV/AIDS STI HCV

RECRUITING NA

Social Media HIV Prevention Intervention for High Risk Rural Women

NCT03456453

HIV/AIDS

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will randomize clusters with groups of participants to an intervention or a standard of care condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections Hepatitis C Virus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Clusters will be randomized to either the intervention or the standard of care.

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

The outcomes assessor will be unaware of the experimental condition.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual Community Intervention

Participants will participate in an online community with structured sessions as well as the ability to communicate freely with others.

Group Type EXPERIMENTAL

Virtual Community Intervention

Intervention Type BEHAVIORAL

Modules of community building, HIV/HCV prevention, drug and service stigma, identification of mental health problems

Standard of Care

Participants will be exposed to what's disseminated within their communities

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type BEHAVIORAL

health websites and county information provided to participants

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Community Intervention

Modules of community building, HIV/HCV prevention, drug and service stigma, identification of mental health problems

Intervention Type BEHAVIORAL

Standard of Care

health websites and county information provided to participants

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lives in target zip codes
* Half not using illicit substances (not including marijuana) currently or in the past
* Half using illicit substances (not including marijuana) currently or in the past